Total Payments
$10,898
2024 Payments
$6,649
Companies
27
Transactions
174
Payment Breakdown by Category
Research$6,271 (57.5%)
Food & Beverage$4,627 (42.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6,271 | 11 | 57.5% |
| Food and Beverage | $4,627 | 163 | 42.5% |
Payments by Type
Research
$6,271
11 transactions
General
$4,627
163 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $4,875 | 1 | $0 (2024) |
| Lumenis BE inc | $1,862 | 1 | $0 (2023) |
| SANOFI PASTEUR INC. | $1,697 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $448.23 | 23 | $0 (2024) |
| Cranial Technologies, Inc | $262.53 | 16 | $0 (2024) |
| Shire North American Group Inc | $220.38 | 12 | $0 (2019) |
| PFIZER INC. | $209.25 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $197.91 | 11 | $0 (2024) |
| Corium, LLC | $161.02 | 9 | $0 (2023) |
| Seqirus USA Inc | $135.23 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,649 | 29 | Becton, Dickinson and Company ($4,875) |
| 2023 | $2,325 | 23 | Lumenis BE inc ($1,862) |
| 2022 | $311.69 | 17 | Merck Sharp & Dohme LLC ($87.47) |
| 2021 | $360.71 | 22 | Merck Sharp & Dohme Corporation ($78.06) |
| 2020 | $153.31 | 10 | Merck Sharp & Dohme Corporation ($50.94) |
| 2019 | $445.37 | 30 | SANOFI PASTEUR INC. ($72.42) |
| 2018 | $294.33 | 20 | Shire North American Group Inc ($94.29) |
| 2017 | $358.97 | 23 | Shire North American Group Inc ($63.11) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Becton, Dickinson and Company | BD Veritor Plus Analyzer (Device) | — | Cash or cash equivalent | $4,875.00 | Research |
| Study: SARS CoV-2 • Category: Diagnostic Testing | ||||||
| 10/30/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/22/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Cranial Orthotic | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: VACCINE | ||||||
| 07/17/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: Vaccines | ||||||
| 06/19/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Cranial Orthotic | ||||||
| 06/05/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Allergy/Immunology | ||||||
| 05/29/2024 | Seqirus USA Inc | Flucelvax (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Vaccines | ||||||
| 05/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PENBRAYA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINES | ||||||
| 05/01/2024 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Vaccines | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $70.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $50.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $50.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $50.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $28.22 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/04/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $24.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/03/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $683.59 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/03/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $265.18 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/03/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $140.00 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 04/03/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $35.31 | Research |
| Study: Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | ||||||
| 03/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $28.59 | General |
| Category: GI | ||||||
| 03/12/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: VACCINES | ||||||
| 03/06/2024 | SANOFI PASTEUR INC. | MENQUADFI (Biological), BEYFORTUS, VAXELIS | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Vaccines | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SARS CoV-2 | Becton, Dickinson and Company | $4,875 | 1 |
| Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | SANOFI PASTEUR INC. | $1,396 | 10 |
About Dr. Steven Twan, MD
Dr. Steven Twan, MD is a Pediatrics healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346323672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Twan, MD has received a total of $10,898 in payments from pharmaceutical and medical device companies, with $6,649 received in 2024. These payments were reported across 174 transactions from 27 companies. The most common payment nature is "" ($6,271).
Ad
Practice Information
- Specialty Pediatrics
- Location Pittsburgh, PA
- Active Since 10/23/2006
- Last Updated 01/31/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1346323672
Products in Payments
- BD Veritor Plus Analyzer (Device) $4,875
- M22 (Device) $1,862
- Doc Band (Device) $262.53
- GARDASIL 9 (Biological) $239.79
- VYVANSE (Drug) $192.56
- ROTATEQ (Biological) $163.07
- BEXSERO (Biological) $145.06
- PREVNAR 13 (Biological) $112.14
- Azstarys (Drug) $91.68
- ImmunoCAP (Device) $90.72
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $87.83
- MENACTRA (Drug) $78.72
- FLUCELVAX QUADRIVALENT (Biological) $72.81
- MYDAYIS (Drug) $69.54
- AZSTARYS (Drug) $69.34
- CUVITRU (Biological) $62.98
- Quillivant XR (Drug) $62.08
- Otovel (Drug) $61.51
- Flucelvax (Biological) $49.79
- TRUMENBA (Biological) $47.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Pittsburgh
Mark Blatter, Md, MD
Pediatrics — Payments: $380,897
Pediatrics $380,897
Todd Wolynn, Md, MD
Pediatrics — Payments: $265,178
Pediatrics $265,178
Dr. Donald Middleton, Md, MD
Pediatrics — Payments: $200,541
Pediatrics $200,541
Hoda Abdel-Hamid, Md, MD
Pediatrics — Payments: $131,468
Pediatrics $131,468
Dr. Shilpa Jain, Md, Mph, MD, MPH
Pediatrics — Payments: $103,724
Pediatrics $103,724
Dr. Frederico Xavier, M.d, M.D
Pediatrics — Payments: $72,570
Pediatrics $72,570